BACKGROUND AND METHODS. The prevention of Tay-Sachs disease (GM2 gangliosidosis, type 1) depends on the identification of carriers of the gene for this autosomal recessive disorder. We compared the enzyme-based test widely used in screening for Tay-Sachs disease with a test based on analysis of DNA. We developed methods to detect the three mutations in the HEXA gene that occur with high frequency among Ashkenazi Jews: two mutations cause infantile Tay-Sachs disease, and the third causes the adult-onset form of the disease. DNA segments containing these mutation sites were amplified with the polymerase chain reaction and analyzed for the presence of the mutations. RESULTS. Among 62 Ashkenazi obligate carriers of Tay-Sachs disease, the three specific mutations accounted for all but one of the mutant alleles (98 percent). In 216 Ashkenazi carriers identified by the enzyme test, DNA analysis showed that 177 (82 percent) had one of the identified mutations. Of the 177, 79 percent had the exon 11 insertion mutation, 18 percent had the intron 12 splice-junction mutation, and 3 percent had the less severe exon 7 mutation associated with adult-onset disease. The results of the enzyme tests in the 39 subjects (18 percent) who were defined as carriers but in whom DNA analysis did not identify a mutant allele were probably false positive (although there remains some possibility of unidentified mutations). In addition, of 152 persons defined as noncarriers by the enzyme-based test, 1 was identified as a carrier by DNA analysis (i.e., a false negative enzyme-test result). CONCLUSIONS. The increased specificity and predictive value of the DNA-based test make it a useful adjunct to the diagnostic tests currently used to screen for carriers of Tay-Sachs disease. Although some false positive results may be desirable on an enzyme-based test that is used in screening, the DNA test allows precise definition of the carrier state for the known mutations.
Source Information
Research Institute, Hospital for Sick Children, Toronto, Canada.
This article has been cited by other articles:
Martin, D. C., Mark, B. L., Triggs-Raine, B. L., Natowicz, M. R.
(2007). Evaluation of the Risk for Tay-Sachs Disease in Individuals of French Canadian Ancestry Living in New England. Clin. Chem.
53: 392-398
[Abstract][Full Text]
Maegawa, G. H. B., Stockley, T., Tropak, M., Banwell, B., Blaser, S., Kok, F., Giugliani, R., Mahuran, D., Clarke, J. T.R.
(2006). The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported. Pediatrics
118: e1550-e1562
[Abstract][Full Text]
Rozenberg, R., Kok, F., Burin, M.G., Sa Miranda, M.C., Vasques, C., Henriques-Souza, A.M.M., Giugliani, R., Vainzof, M., Pereira, L.V.
(2006). Diagnosis and Molecular Characterization of Nonclassic Forms of Tay-Sachs Disease in Brazil. J Child Neurol
21: 540-544
[Abstract]
Rucker, J. C., Shapiro, B. E., Han, Y. H., Kumar, A. N., Garbutt, S., Keller, E. L., Leigh, R. J.
(2004). Neuro-ophthalmology of late-onset Tay-Sachs disease (LOTS). Neurology
63: 1918-1926
[Abstract][Full Text]
Barlow-Stewart, K, Burnett, L, Proos, A, Howell, V, Huq, F, Lazarus, R, Aizenberg, H
(2003). A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. J. Med. Genet.
40: e45-45
[Full Text]
Post, J. C., Ehrlich, G. D.
(2000). The Impact of the Polymerase Chain Reaction in Clinical Medicine. JAMA
283: 1544-1546
[Full Text]
Antonini, G., Ceschin, V., Morino, S., Fiorelli, M., Gragnani, F., Mengarelli, A., Iori, A. P., Arcese, W.
(1998). Early neurologic complications following allogeneic bone marrow transplant for leukemia: A prospective study. Neurology
50: 1441-1445
[Abstract][Full Text]
Migita, D. S., Devereaux, M. W., Tomsak, R. L.
(1997). Cocaine and pupillary-sparing oculomotor nerve paresis. Neurology
49: 1466-1467
[Full Text]
Eng, C. M., Schechter, C., Robinowitz, J., Fulop, G., Burgert, T., Levy, B., Zinberg, R., Desnick, R. J.
(1997). Prenatal Genetic Carrier Testing Using Triple Disease Screening. JAMA
278: 1268-1272
[Abstract]
Qureshi, A. I., Akbar, M. S., Czander, E., Safdar, K., Janssen, R. S., Frankel, M. R.
(1997). Crack cocaine use and stroke in young patients. Neurology
48: 341-345
[Abstract][Full Text]
De Gasperi, R., Sosa, M. A. G., Battistini, S., Yeretsian, J., Raghavan, S., Zelnik, N., Leshinsky, E., Kolodny, E. H.
(1996). Late-onset G sub M2 gangliosidosis: Ashkenazi Jewish family with an exon 5 mutation (Tyr sup 180 right arrow His) in the Hex A alpha-chain gene. Neurology
47: 547-552
[Abstract][Full Text]
Aggarwal, S. K., Williams, V., Levine, S. R., Cassin, B. J., Garcia, J. H.
(1996). Cocaine-associated intracranial hemorrhage: Absence of vasculitis in 14 cases. Neurology
46: 1741-1743
[Abstract][Full Text]
Nolte, K. B., Brass, L. M., Fletterick, C. F.
(1996). Intracranial hemorrhage associated with cocaine abuse: A prospective autopsy study. Neurology
46: 1291-1291
[Abstract][Full Text]
Kaback, M., Lim-Steele, J., Dabholkar, D., Brown, D., Levy, N., Zeiger, K., for the International TSD Data Collection Network,
(1993). Tay-Sachs Disease-- Carrier Screening, Prenatal Diagnosis, and the Molecular Era: An International Perspective, 1970 to 1993. JAMA
270: 2307-2315
[Abstract]
Arisoy, A. E., Ozden, S., Arisoy, E. S., Kocabay, K., Guvenc, H., Tunnessen, W. W. Jr
(1992). Picture of the Month. Arch Pediatr Adolesc Med
146: 767-768
[Abstract]
Previous
